Back to top

rsi: Archive

Zacks Equity Research

Down -14.13% in 4 Weeks, Here's Why CARGO Therapeutics, Inc. (CRGX) Looks Ripe for a Turnaround

CARGO Therapeutics, Inc. (CRGX) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

CRGXPositive Net Change

Zacks Equity Research

Spero Therapeutics (SPRO) Loses -9.32% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Spero Therapeutics (SPRO) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

SPROPositive Net Change

Zacks Equity Research

Down -30.89% in 4 Weeks, Here's Why Lyell Immunopharma (LYEL) Looks Ripe for a Turnaround

Lyell Immunopharma (LYEL) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

LYELPositive Net Change

Zacks Equity Research

After Plunging -16.78% in 4 Weeks, Here's Why the Trend Might Reverse for Tenet (THC)

The heavy selling pressure might have exhausted for Tenet (THC) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

THCPositive Net Change

Zacks Equity Research

Here's Why enGene Holdings Inc. (ENGN) is Poised for a Turnaround After Losing -16.9% in 4 Weeks

enGene Holdings Inc. (ENGN) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

ENGNNegative Net Change

Zacks Equity Research

After Plunging -30.17% in 4 Weeks, Here's Why the Trend Might Reverse for Foghorn Therapeutics (FHTX)

The heavy selling pressure might have exhausted for Foghorn Therapeutics (FHTX) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

FHTXPositive Net Change

Zacks Equity Research

After Plunging -14.03% in 4 Weeks, Here's Why the Trend Might Reverse for Uber (UBER)

The heavy selling pressure might have exhausted for Uber (UBER) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

UBERPositive Net Change

Zacks Equity Research

Maximus (MMS) Loses -21.83% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Maximus (MMS) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

MMSPositive Net Change

Zacks Equity Research

Down -6.3% in 4 Weeks, Here's Why CareTrust REIT (CTRE) Looks Ripe for a Turnaround

CareTrust REIT (CTRE) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

CTRENegative Net Change

Zacks Equity Research

Easterly Government Properties (DEA) Loses -13.74% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Easterly Government Properties (DEA) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

DEAPositive Net Change

Zacks Equity Research

After Plunging -10.73% in 4 Weeks, Here's Why the Trend Might Reverse for Mach Natural Resources LP (MNR)

Mach Natural Resources LP (MNR) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

MNRPositive Net Change

Zacks Equity Research

Here's Why SAIC (SAIC) is Poised for a Turnaround After Losing -22.31% in 4 Weeks

SAIC (SAIC) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

SAICNegative Net Change

Zacks Equity Research

Down -20.02% in 4 Weeks, Here's Why You Should You Buy the Dip in CACI International (CACI)

The heavy selling pressure might have exhausted for CACI International (CACI) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

CACINegative Net Change

Zacks Equity Research

Here's Why Galectin Therapeutics (GALT) is Poised for a Turnaround After Losing -31.83% in 4 Weeks

The heavy selling pressure might have exhausted for Galectin Therapeutics (GALT) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

GALTNegative Net Change

Zacks Equity Research

After Plunging -30.29% in 4 Weeks, Here's Why the Trend Might Reverse for Relay Therapeutics (RLAY)

Relay Therapeutics (RLAY) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

RLAYPositive Net Change

Zacks Equity Research

Booz Allen (BAH) Loses -18.83% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Booz Allen (BAH) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

BAHPositive Net Change

Zacks Equity Research

Down -54.05% in 4 Weeks, Here's Why Phathom Pharmaceuticals (PHAT) Looks Ripe for a Turnaround

Phathom Pharmaceuticals (PHAT) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

PHATNegative Net Change

Zacks Equity Research

MarketAxess (MKTX) Loses -9.63% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

MarketAxess (MKTX) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

MKTXNegative Net Change

Zacks Equity Research

After Plunging -15.12% in 4 Weeks, Here's Why the Trend Might Reverse for Gevo (GEVO)

Gevo (GEVO) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

GEVOPositive Net Change

Zacks Equity Research

Here's Why Phunware (PHUN) is Poised for a Turnaround After Losing -36.04% in 4 Weeks

The heavy selling pressure might have exhausted for Phunware (PHUN) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

PHUNPositive Net Change

Zacks Equity Research

Nouveau Monde Graphite (NMG) Loses -12.06% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

The heavy selling pressure might have exhausted for Nouveau Monde Graphite (NMG) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

NMGPositive Net Change

Zacks Equity Research

Down -15.63% in 4 Weeks, Here's Why You Should You Buy the Dip in ACM Research (ACMR)

ACM Research (ACMR) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

ACMRPositive Net Change

Zacks Equity Research

Here's Why Vista Outdoor (GEAR) is Poised for a Turnaround After Losing -56.92% in 4 Weeks

Vista Outdoor (GEAR) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

GEARNegative Net Change

Zacks Equity Research

GDEV Inc. (GDEV) Loses -15.68% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

GDEV Inc. (GDEV) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

GDEVPositive Net Change

Zacks Equity Research

After Plunging -38.05% in 4 Weeks, Here's Why the Trend Might Reverse for Select Medical (SEM)

The heavy selling pressure might have exhausted for Select Medical (SEM) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

SEMPositive Net Change